Cargando…
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
BACKGROUND: Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is the third most common cause of cancer-related mortality worldwide. In the last years the multikinase inhibitor sorafenib has been used for advanced HCC, but some patients do not benefit from this thera...
Autores principales: | Salvi, Alessandro, Conde, Isabel, Abeni, Edoardo, Arici, Bruna, Grossi, Ilaria, Specchia, Claudia, Portolani, Nazario, Barlati, Sergio, De Petro, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029516/ https://www.ncbi.nlm.nih.gov/pubmed/24330766 http://dx.doi.org/10.1186/1476-4598-12-162 |
Ejemplares similares
-
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
por: Grossi, Ilaria, et al.
Publicado: (2016) -
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
por: SALVI, ALESSANDRO, et al.
Publicado: (2012) -
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells
por: Abeni, Edoardo, et al.
Publicado: (2017) -
Biological Function of MicroRNA193a-3p in Health and Disease
por: Grossi, Ilaria, et al.
Publicado: (2017) -
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells
por: SALVI, ALESSANDRO, et al.
Publicado: (2015)